Do you want BuboFlash to help you learning these things? Or do you want to add or correct something? Click here to log in or create user.

Researchers from six organizations followed a common protocol using data from administrative claims and electronic health records to assess real-world end points, including overall survival (rwOS), time to next treatment, time to treatment discontinuation (rwTTD), time to progression, and progression- free survival, among patients with advanced non–small-cell lung cancer treated with programmed death 1/programmed death-ligand 1 inhibitors in real-world settings.
If you want to change selection, open document below and click on "Move attachment"


owner: fgruber - (no access) - Stewart et al. - An Exploratory Analysis of Real-World End Points f.pdf, p1


statusnot read reprioritisations
last reprioritisation on suggested re-reading day
started reading on finished reading on



Do you want to join discussion? Click here to log in or create user.